Literature DB >> 7082662

The transport of chloroquine across human erythrocyte membranes is mediated by a simple symmetric carrier.

A Yayon, H Ginsburg.   

Abstract

The kinetic properties of the mediated transport of chloroquine in human erythrocytes are investigated. The high rates of translocation across the cell membrane and high adsorbance properties to glass surfaces have led to the development of new techniques for measuring initial rates of transport. Three different methodological procedures are used to accomplish a complete kinetic characterization of the system. All measurements were done at 25 degrees C. Under zero-trans conditions the system displays complete symmetry, the Michaelis constants being 39.2 +/- 2.4 microM for influx and 36.6 +/- 5.6 microM for efflux. The respective maximal velocities are 206.4 +/- 36.0 microM . min-1 and 190.0 +/- 7.8 microM . min-1. Under equilibrium-exchange conditions the Michaelis constant is 108.6 +/- 15.6 microM and the maximal velocity is 630.3 +/- 50.4 microM . min-1. This 3-fold increase in both K and V over the zero-trans values indicates that the rate-limiting step in the transport of chloroquine is the movement of the unloaded carrier. The kinetic data are consistent with the prediction of a simple carrier model.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082662     DOI: 10.1016/0005-2736(82)90113-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Differences in trans-stimulated chloroquine efflux kinetics are linked to PfCRT in Plasmodium falciparum.

Authors:  Cecilia P Sanchez; Petra Rohrbach; Jeremy E McLean; David A Fidock; Wilfred D Stein; Michael Lanzer
Journal:  Mol Microbiol       Date:  2007-04       Impact factor: 3.501

2.  Time-dependent variability of chloroquine secretion into human saliva.

Authors:  C O Onyeji; F A Ogunbona
Journal:  Pharm World Sci       Date:  1996-12

3.  Erythrocytes as barriers for drug elimination in the isolated rat liver. I. Doxorubicin.

Authors:  H J Lee; W L Chiou
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

4.  Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors.

Authors:  Patricia Urbán; Joan Estelrich; Alberto Adeva; Alfred Cortés; Xavier Fernàndez-Busquets
Journal:  Nanoscale Res Lett       Date:  2011-12-07       Impact factor: 4.703

5.  Machine learning applied on chest x-ray can aid in the diagnosis of COVID-19: a first experience from Lombardy, Italy.

Authors:  Isabella Castiglioni; Davide Ippolito; Matteo Interlenghi; Caterina Beatrice Monti; Christian Salvatore; Simone Schiaffino; Annalisa Polidori; Davide Gandola; Cristina Messa; Francesco Sardanelli
Journal:  Eur Radiol Exp       Date:  2021-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.